Hyphens Pharma International Ltd logo

1J5

SGX

Hyphens Pharma International Ltd

Health CareSingapore

Company Overview

Ticker: 1J5
Exchange: SGX
Sector: Health Care
Industry: -
Market Cap: -
FY End: December
Employees: -

Hyphens Pharma International Limited, together with its subsidiaries, operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally. It operates through Pharmaceutical and Medical Aesthetics; Proprietary Brands; and Digital Platform and E-Pharmacy segments. The Pharmaceutical and Medical Aesthetics segment markets and sells a range of pharmaceutical and medical aesthetics products, including the Stérimar nasal sprays, Bausch+Lomb eye drops, Vivomixx, Fenosup Lidose, and Piascledine products in ASEAN countries. This segment focuses on various therapeutic areas, such as dermatology, pediatrics and neonatology, allergy, otorhinolaryngology, orthopedics and rheumatology, radiology, cardiology and interventional cardiology, ophthalmology, gastroenterology, psychiatry, family medicine, and medical aesthetics. Its Proprietary Brands segment develops, markets, and sells dermatological products comprising Ceradan, TDF, and CG210; health supplements under the Ocean Health brand covering areas, such as heart, joint, physical, cognitive, eye, and health; and pharmaceuticals. The Digital Platform and E-Pharmacy segment operates a digital platform that services procurement needs of healthcare professionals, healthcare institutions, and retail pharmacies primarily in Singapore. The company was formerly known as Hyphens Pharma International Pte Ltd and changed its name to Hyphens Pharma International Limited in May 2018. Hyphens Pharma International Limited was founded in 1998 and is headquartered in Singapore.

Leadership Team

LC

Chief Technology Officer

SW

Executive Chairman & CEO

YJ

Managing Director of Pan-Malayan Pharmaceuticals & Novem Healthcare

TL

Head of HR & Admin

YZ

Chief Financial Officer

SA

Head of Regulatory Affairs

YA

Chief Operating Officer

AF

Country Head of Malaysia

JS

Country Head of Philippines

JI

Country Head of Indonesia

TK

Director

HW

Independent Director, Audit Committee Chairman

TS

Independent Director, Audit Committee Member

YM

Key Management Personnel

DL

Key Management Personnel

JY

Key Management Personnel

ZY

Key Management Personnel

LS

Director

LS

Chairman and Chief Executive Officer

TK

Non-Executive Director

HW

Independent Director, Chairman of Audit Committee

NE

Independent Director, Chairman of Remuneration Committee

AL

Independent Director

CK

Independent Director

NE

Independent Director, Audit Committee Member

CK

Independent Director, Audit Committee Member

Former

TC

Executive Director

Recent Announcements

No announcements yet.

External Auditor

RSM SG Assurance LLP
Tenure2 years(since 1 Jan 2023)

Auditor History

RSM SG Assurance LLP1 Jan 2023 — present
RSM SG Assurance LLP1 Jan 2023 — 1 Jan 2025

Analyst Coverage

noneconsensus
2 analysts

Target Price

Low$0.40
Mean
$0.41+48.2%
High$0.43
Current Price$0.28

Based on broker consensus estimates. Not financial advice.

Price Chart

Insufficient price data

Key Metrics

P/E Ratio15.75
P/B Ratio1.39
EV/EBITDA4.83
Dividend Yield4.8%
ROE8.3%
ROA6.9%
Net Margin3.3%
Debt/Equity0.13
Net Debt/EBITDA-1.02
FCF Yield-

Governance Score

-

SGX Code of Corporate Governance

StocksSG provides data for informational purposes only. This is not financial advice. Information may contain errors or be outdated. Always verify data independently and consult a licensed financial adviser before making investment decisions.

Data sources · Full disclaimer